Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Antonaci
Observed names:
ANTONACI, LAURA,
Antonaci L,
Antonaci Laura,
Antonaci, Laura,
L. Antonaci
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Centro Clinico Nemo
Observed institutions:
Università Cattolica del Sacro Cuore,
F. Hoffmann-La Roche AG,
Agostino Gemelli University Polyclinic,
ASL Roma,
Centro Clinico Nemo,
Istituti di Ricovero e Cura a Carattere Scientifico,
Novartis Gene Therapies, Inc. (United States),
Sapienza University of Rome
show all 8
ORCID:
0000-0003-4753-8441
Observed ORCID:
0000-0003-4753-8441
OpenAlex ID:
A5091829840
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
2021
·
Eugenio Mercuri
, Francesco Muntoni
, et al.
·
The Lancet Neurology
·
310
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
2021
·
Eugenio Mercuri
, Nicolas Deconinck
, et al.
·
The Lancet Neurology
·
269
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy
2017
·
Maria C. Pera
, Giorgia Coratti
, et al.
·
BMC Neurology
·
210
PDF
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
2021
·
Giorgia Coratti
, Costanza Cutrona
, et al.
·
Orphanet Journal of Rare Diseases
·
170
Developmental milestones in type I spinal muscular atrophy
2016
·
Roberto De Sanctis
, Giorgia Coratti
, et al.
·
Neuromuscular Disorders
·
151
PDF
Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial
2021
·
Laurent Servais
, Eugenio Mercuri
, et al.
·
Nucleic Acid Therapeutics
·
140
Clinical Variability in Spinal Muscular Atrophy Type III
2020
·
Giorgia Coratti
, Sonia Messina
, et al.
·
Annals of Neurology
·
84
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?
2020
·
Maria Carmela Pera
, Giorgia Coratti
, et al.
·
PLoS ONE
·
78
PDF
Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy
2022
·
Marika Pane
, Giorgia Coratti
, et al.
·
Annals of Clinical and Translational Neurology
·
69
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
2023
·
Claudia A. Chiriboga
, Claudio Bruno
, et al.
·
Neurology and Therapy
·
66
PDF
Cortical sources of resting state EEG rhythms are abnormal in dyslexic children
2012
·
Claudio Babiloni
, Giacomo Stella
, et al.
·
Clinical Neurophysiology
·
66
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients
2019
·
Claudia Brogna
, Lara Cristiano
, et al.
·
Journal of Neurology
·
60
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen
2021
·
Giorgia Coratti
, Marika Pane
, et al.
·
Neuromuscular Disorders
·
58
Development of an academic disease registry for spinal muscular atrophy
2019
·
Eugenio Mercuri
, Richard Finkel
, et al.
·
Neuromuscular Disorders
·
56
Long-term progression in type II spinal muscular atrophy: A retrospective observational study
2019
·
Eugenio Mercuri
, Simona Lucibello
, et al.
·
Neurology
·
54
PDF
New therapies for spinal muscular atrophy: where we stand and what is next
2023
·
Laura Antonaci
, Maria Carmela Pera
, et al.
·
European Journal of Pediatrics
·
52
PDF
Different trajectories in upper limb and gross motor function in spinal muscular atrophy
2021
·
Giorgia Coratti
, Maria Carmela Pera
, et al.
·
Muscle & Nerve
·
51
PDF
6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction
2017
·
Maria Carmela Pera
, Marco Luigetti
, et al.
·
Neuromuscular Disorders
·
51
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy
2019
·
Sonia Messina
, Anna Lia Frongia
, et al.
·
Neuromuscular Disorders
·
50
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy
2021
·
Maria Carmela Pera
, Giorgia Coratti
, et al.
·
Annals of Clinical and Translational Neurology
·
49
PDF
The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys
2014
·
Marika Pane
, Elena Stacy Mazzone
, et al.
·
PLoS Currents
·
48
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes
2021
·
Giorgia Coratti
, Maria Carmela Pera
, et al.
·
Neuromuscular Disorders
·
34
Sleep disorders in spinal muscular atrophy
2016
·
Maria C. Pera
, Domenico M. Romeo
, et al.
·
Sleep Medicine
·
32
Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes
2014
·
Serena Sivo
, Elena Mazzone
, et al.
·
Neuromuscular Disorders
·
31
Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019
2020
·
Eugenio Mercuri
, Sonia Messina
, et al.
·
Neuromuscular Disorders
·
26
PDF
Show more works
View as search
Works count:
57
Citation count:
2,425
H-index:
25
I10-index:
33
Year
Topic
Type